Literature DB >> 22728316

Thinking through postoperative cognitive dysfunction: How to bridge the gap between clinical and pre-clinical perspectives.

Iris B Hovens1, Regien G Schoemaker, Eddy A van der Zee, Erik Heineman, Gerbrand J Izaks, Barbara L van Leeuwen.   

Abstract

Following surgery, patients may experience cognitive decline, which can seriously reduce quality of life. This postoperative cognitive dysfunction (POCD) is mainly seen in the elderly and is thought to be mediated by surgery-induced inflammatory reactions. Clinical studies tend to define POCD as a persisting, generalised decline in cognition, without specifying which cognitive functions are impaired. Pre-clinical research mainly describes early hippocampal dysfunction as a consequence of surgery-induced neuroinflammation. These different approaches to study POCD impede translation between clinical and pre-clinical research outcomes and may hamper the development of appropriate interventions. This article analyses which cognitive domains deteriorate after surgery and which brain areas might be involved. The most important outcomes are: (1) POCD encompasses a wide range of cognitive impairments; (2) POCD affects larger areas of the brain; and (3) individual variation in the vulnerability of neuronal networks to neuroinflammatory mechanisms may determine if and how POCD manifests itself. We argue that, for pre-clinical and clinical research of POCD to advance, the effects of surgery on various cognitive functions and brain areas should be studied. Moreover, in addition to general characteristics, research should take inter-relationships between cognitive complaints and physical and mental characteristics into account.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22728316     DOI: 10.1016/j.bbi.2012.06.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  41 in total

1.  Propofol protects against angiotensin II-induced mouse hippocampal HT22 cells apoptosis via inhibition of p66Shc mitochondrial translocation.

Authors:  Minmin Zhu; Jiawei Chen; Meilin Wen; Zhirong Sun; Xia Sun; Jing Wang; Changhong Miao
Journal:  Neuromolecular Med       Date:  2014-08-24       Impact factor: 3.843

2.  Resveratrol pretreatment attenuates the isoflurane-induced cognitive impairment through its anti-inflammation and -apoptosis actions in aged mice.

Authors:  Xiao-Min Li; Mai-Tao Zhou; Xing-Ming Wang; Mu-Huo Ji; Zhi-Qiang Zhou; Jian-Jun Yang
Journal:  J Mol Neurosci       Date:  2013-10-15       Impact factor: 3.444

3.  The psychological and neurocognitive consequences of critical illness. A pragmatic review of current evidence.

Authors:  Olivia Clancy; Trudi Edginton; Annalisa Casarin; Marcela P Vizcaychipi
Journal:  J Intensive Care Soc       Date:  2015-01-26

4.  Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.

Authors:  Jeanne S Mandelblatt; Tim A Ahles; James C Root; Xingtao Zhou; Jaeil Ahn; Brent J Small; Wanting Zhai; Traci Bethea; Judith E Carroll; Harvey Jay Cohen; Asma Dilawari; Martine Extermann; Deena Graham; Claudine Isaacs; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Zev M Nakamura; Sunita K Patel; Kelly Rentscher; Andrew J Saykin; Kathleen Van Dyk
Journal:  Breast Cancer Res Treat       Date:  2022-05-19       Impact factor: 4.624

5.  Social enrichment attenuates chemotherapy induced pro-inflammatory cytokine production and affective behavior via oxytocin signaling.

Authors:  William H Walker; O Hecmarie Meléndez-Fernández; Jordan L Pascoe; Ning Zhang; A Courtney DeVries
Journal:  Brain Behav Immun       Date:  2020-07-29       Impact factor: 7.217

6.  Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice.

Authors:  Xiao-Min Li; Fan Su; Mu-Huo Ji; Guang-Fen Zhang; Li-Li Qiu; Min Jia; Jun Gao; Zhongcong Xie; Jian-Jun Yang
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

Review 7.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

8.  PGE2-EP3 signaling exacerbates hippocampus-dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity-related proteins in aged mice.

Authors:  Jing-Yu Xiao; Bing-Rui Xiong; Wen Zhang; Wen-Chang Zhou; Hui Yang; Feng Gao; Hong-Bing Xiang; Anne Manyande; Xue-Bi Tian; Yu-Ke Tian
Journal:  CNS Neurosci Ther       Date:  2018-02-27       Impact factor: 5.243

9.  Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.

Authors:  Sigal Liraz-Zaltsman; Rami Yaka; Dalia Shabashov; Esther Shohami; Anat Biegon
Journal:  J Mol Neurosci       Date:  2016-07-16       Impact factor: 3.444

10.  Cannabinoid receptor 2 deficiency enhances isoflurane-induced spatial cognitive impairment in adult mice by affecting neuroinflammation, neurogenesis and neuroplasticity.

Authors:  Chao Li; Jingpu Shi; Jiaguang Sun; Yuanyuan Shi; Huiqun Jia
Journal:  Exp Ther Med       Date:  2021-06-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.